|
Novel Alternative Drugs for Hospital-acquired Methicillin-Resistant Staphylococcus aureus Infection |
|---|---|
| รหัสดีโอไอ | |
| Creator | Teerapong Monmaturapoj |
| Title | Novel Alternative Drugs for Hospital-acquired Methicillin-Resistant Staphylococcus aureus Infection |
| Publisher | Faculty of Pharmaceutical Sciences KKU, MSU, UBU |
| Publication Year | 2558 |
| Journal Title | Isan Journal of Pharmaceutical Sciences |
| Journal Vol. | 11 |
| Journal No. | 3 |
| Page no. | 1-19 |
| Keyword | Daptomycin, Linezolid, MRSA, Tigecycline, Vancomycin |
| ISSN | 19050852 |
| Abstract | Nowadays, MRSA is a common cause of nosocomial infection and is often associated with invasive infections and high rates of mortality. Vancomycin has remained the mainstay of therapy for serious gram-positive infections including MRSA. However, therapeutic failures with vancomycin have been increasingly reported from many studies. Hence, it has been associated with suboptimal outcomes. New agents for the treatment of MRSA are required. Novel alternative drugs for MRSA infection such as linezolid, daptomycin and tigecycline which available in Thailand have been substituted with vancomycin. These new medications will be considered for patient with failure or unsatisfied response from vancomycin treatment owing to VISA or VRSA infection. The purpose of this review is to discuss the incidence of MRSA in Thailand, treatment failure of vancomycin and alternative treatment for MRSA infection from several clinical studies. This information will be useful for physicians, pharmacists and healthcare personals for considering the appropriate treatment of MRSA in order to maximize efficacy and decrease resistance rate especially VISA and VRSA. |
